Fully tolerized, self T cells—which share a very similar transcriptional profile to fixed, dysfunctional, tumor-specific T cells [70]—are completely resistant to single target checkpoint blockade treatment as well as the combination of anti-CTLA-4 and anti-PD-1. Here, CTLA4 is linked to neoplasm.